1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > EU5 Orthobiologic Procedures Outlook to 2021

EU5 Orthobiologic Procedures Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 25 pages

EU5 Orthobiologic Procedures Outlook to 2021

Summary

GlobalData’s new report, "EU5 Orthobiologic Procedures Outlook to 2021", provides key procedures data on the EU5 Orthobiologic Procedures (Bone Graft Procedures).

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Orthobiologics Procedures (Bone Graft Procedures) volumes.
- Data is provided from 2007 to 2014 and forecast to 2021.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

EU5 Orthobiologic Procedures Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Definitions of Procedures Covered in the Report 4
3 Orthobiologic Procedures, EU5 5
3.1 Orthobiologic Procedures, EU5, 2007-2014 5
3.2 Orthobiologic Procedures, EU5, 2014-2021 6
4 Orthobiologic Procedures, France 7
4.1 Orthobiologic Procedures, France, 2007-2014 7
4.2 Orthobiologic Procedures, France, 2014-2021 8
5 Orthobiologic Procedures, Germany 9
5.1 Orthobiologic Procedures, Germany, 2007-2014 9
5.2 Orthobiologic Procedures, Germany, 2014-2021 10
6 Orthobiologic Procedures, Italy 11
6.1 Orthobiologic Procedures, Italy, 2007-2014 11
6.2 Orthobiologic Procedures, Italy, 2014-2021 12
7 Orthobiologic Procedures, Spain 13
7.1 Orthobiologic Procedures, Spain, 2007-2014 13
7.2 Orthobiologic Procedures, Spain, 2014-2021 14
8 Orthobiologic Procedures, United Kingdom 15
8.1 Orthobiologic Procedures, United Kingdom, 2007-2014 15
8.2 Orthobiologic Procedures, United Kingdom, 2014-2021 16
9 Appendix 17
9.1 Research Methodology 18
9.1.1 Coverage 18
9.1.2 Secondary Research 18
9.1.3 Primary Research 19
9.1.4 Market Modeling and Forecasting 20
9.1.5 Company Share Analysis 23
9.1.6 Distribution Share Analysis 24
9.2 Expert Panel 25
9.3 GlobalData Consulting 25
9.4 Contact Us 25
9.5 Disclaimer 25

1.1 List of Tables
Table 1: Orthobiologic Procedures, EU5, Historic, 2007-2014 5
Table 2: Orthobiologic Procedures, EU5, Forecast, 2014-2021 6
Table 3: Orthobiologic Procedures, France, Historic, 2007-2014 7
Table 4: Orthobiologic Procedures, France, Forecast, 2014-2021 8
Table 5: Orthobiologic Procedures, Germany, Historic, 2007-2014 9
Table 6: Orthobiologic Procedures, Germany, Forecast, 2014-2021 10
Table 7: Orthobiologic Procedures, Italy, Historic, 2007-2014 11
Table 8: Orthobiologic Procedures, Italy, Forecast, 2014-2021 12
Table 9: Orthobiologic Procedures, Spain, Historic, 2007-2014 13
Table 10: Orthobiologic Procedures, Spain, Forecast, 2014-2021 14
Table 11: Orthobiologic Procedures, United Kingdom, Historic, 2007-2014 15
Table 12: Orthobiologic Procedures, United Kingdom, Forecast, 2014-2021 16
Table 13: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 20

1.2 List of Figures
Figure 1: Orthobiologic Procedures, EU5, Historic, 2007-2014 5
Figure 2: Orthobiologic Procedures, EU5, Forecast, 2014-2021 6
Figure 3: Orthobiologic Procedures, France, Historic, 2007-2014 7
Figure 4: Orthobiologic Procedures, France, Forecast, 2014-2021 8
Figure 5: Orthobiologic Procedures, Germany, Historic, 2007-2014 9
Figure 6: Orthobiologic Procedures, Germany, Forecast, 2014-2021 10
Figure 7: Orthobiologic Procedures, Italy, Historic, 2007-2014 11
Figure 8: Orthobiologic Procedures, Italy, Forecast, 2014-2021 12
Figure 9: Orthobiologic Procedures, Spain, Historic, 2007-2014 13
Figure 10: Orthobiologic Procedures, Spain, Forecast, 2014-2021 14
Figure 11: Orthobiologic Procedures, United Kingdom, Historic, 2007-2014 15
Figure 12: Orthobiologic Procedures, United Kingdom, Forecast, 2014-2021 16
Figure 13: GlobalData Epidemiology-Based Forecasting Model 22
Figure 14: GlobalData Capital Equipment-Based Forecasting Model 23
Figure 15: Primary Interviews by Participant Type (%) 24

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.